Biomea Fusion, Inc. (NASDAQ: BMEA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT BIOMEA FUSION, INC.

Biomea Fusion, Inc. (NASDAQ: BMEA)
Listen to this Section


$1.29
-0.0850 ( -6.20% ) 912.0K

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

Market Data


Open $1.29
Previous Close $1.37
Volume 912.0K
Market Cap $93.99M
Day Range $1.28 - $1.41
52 Week Range $0.87 - $3.08
Shares Outstanding 72.30M
Change % -6.20%
Net Change ▼ -0.0850
Insider Ownership 0.00%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2021
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -194,100.00

Date Type Amount Purchased Purchaser
2024-10-01 Buy 10000.00 Hitchcock Michael J.M.
2024-06-13 Sale -51025.00 Chen Bihua
2024-06-13 Sale -51025.00 Hitchcock Michael J.M.
2024-06-13 Sale -51025.00 Faust Elizabeth
2024-06-13 Sale -51025.00 Ray Sumita

SEC Filings


Form Type Description Pages Date
3 Insider transactions 2 Jul 24, 2025
8-k 8K-related 14 Jul 24, 2025
8-k 8K-related 15 Jun 20, 2025
8-k 8K-related 19 Jun 18, 2025
8-k 8K-related 69 Jun 17, 2025
8-k 8K-related 12 Jun 13, 2025
4 Insider transactions 1 Jun 13, 2025
4 Insider transactions 1 Jun 13, 2025
4 Insider transactions 1 Jun 13, 2025
4 Insider transactions 1 Jun 13, 2025

Latest News


× Before browsing our site, please accept our cookies policy